Drug Profile
Research programme: Pim serine/threonine kinase inhibitors - Astex Pharmaceuticals
Alternative Names: SG 0407; SGI-1751; SGI-1753; SGI-1758; SGI-Pim-1-1751; SGI-Pim-1-1753; SGI-Pim-1-1758Latest Information Update: 19 Apr 2012
Price :
$50
*
At a glance
- Originator SuperGen
- Developer Astex Pharmaceuticals
- Class Small molecules
- Mechanism of Action Protein-serine-threonine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 15 Mar 2012 Discontinued - Preclinical for Cancer in USA (PO)
- 23 Apr 2009 This programme is still in active development
- 10 Dec 2007 This programme is still in active development